Prostate-related conditions, including benign prostatic hyperplasia, prostatitis, and prostate cancer, represent significant health concerns, particularly among aging men. This study utilized a comprehensive review of existing literature and case studies to explore the effectiveness of integrative approaches, emphasizing nutrition, exercise, and lifestyle modifications, in managing prostate diseases. Data were collected from peer-reviewed journals, clinical trials, and meta-analyses focusing on dietary patterns, physical activity, and complementary therapies. The findings were synthesized to provide evidence-based recommendations. Results highlight that plant-based diets, rich in fruits, vegetables, whole grains, and healthy fats, demonstrate protective effects against prostate conditions, while diets high in saturated fats and processed foods increase risk. Specific bioactive compounds,such as lycopene, omega-3 fatty acids, and polyphenols, were linked to reduced disease progression. Physical activity emerged as a key component, enhancing hormonal balance, reducing inflammation, and improving survival rates in prostate cancer patients. Aerobic and resistance exercises were particularly effective in mitigating treatment side effects such as fatigue and muscle loss. Stress-reduction techniques, including mindfulness and yoga, alongside moderated alcohol consumption, further improved psychological well-being and overall prostate health. Integrative approaches, combining conventional treatments with holistic care, demonstrated enhanced outcomes by addressing the physical, emotional, and social dimensions of prostate disease. Emerging fields such as nutrigenomics and natural products offer opportunities for personalized interventions, paving the way for innovative management strategies. This study underscores the potential of integrative methods to improve disease outcomes, prevent progression, and enhance the quality of life for men affected by prostate conditions, advocating for their inclusion in prostate disease management protocols.

Background Benign prostatic hyperplasia [BPH] is a prevalent condition among aging men, characterized by prostate gland enlargement leading to lower urinary tract symptoms [LUTS]. Conventional treatments like alpha-blockers and 5-alpha-reductase inhibitors, though effective, often result in adverse effects. This has spurred interest in phytotherapy, leveraging plant-derived compounds to mitigate BPH symptoms due to their safety, cost-effectiveness, and patient preference. Method The review highlighted 84 studies involving diverse plants and bioactive compounds. Prominent examples include Serenoa repens [saw palmetto], Urtica dioica [nettle root], Cucurbita pepo [pumpkin seed], and Pygeum africanum [African cherry]. These plants exhibit mechanisms such as 5α-reductase inhibition, anti-inflammatory effects, and modulation of oxidative stress. Clinical and preclinical findings demonstrate improved urinary flow, reduced prostate volume, and alleviated LUTS. However, variability in methodologies, extract preparations, and dosages poses challenges to standardization. Results The review highlighted 84 studies involving diverse plants and bioactive compounds. Prominent examples include Serenoa repens [saw palmetto], Urtica dioica [nettle root], Cucurbita pepo [pumpkin seed], and Pygeum africanum [African cherry]. These plants exhibit mechanisms such as 5α-reductase inhibition, anti-inflammatory effects, and modulation of oxidative stress. Clinical and preclinical findings demonstrate improved urinary flow, reduced prostate volume, and alleviated LUTS. However, variability in methodologies, extract preparations, and dosages poses challenges to standardization. Conclusion Phytotherapy holds significant potential in BPH management, offering symptom relief with minimal side effects. While promising, further robust clinical trials are essential to validate efficacy, establish standardized protocols, and ensure integration into mainstream therapeutic frameworks.

Background Iron Deficiency Anaemia (IDA) is a major public health challenge in East Africa, particularly affecting children and women. Conventional therapies are often limited by accessibility and cost, prompting interest in plant-based interventions as affordable and locally available alternatives. This review explores the potential of medicinal plants in managing IDA, focusing on their phytochemical composition, mechanisms of action, and haematological effects. Methods A systematic search of PubMed, Scopus, and Web of Science databases was conducted on July 17, 2024. The search strategy utilised Boolean operators and keywords related to plants, IDA management, and East Africa. Studies meeting inclusion criteria were peer-reviewed articles published in English that evaluated plant-based treatments for IDA in preclinical or clinical trials. A total of 30 eligible studies were included after screening and quality assessment following PRISMA guidelines. Results The review identified plants such as Moringa oleifera , Phyllanthus emblica , and Telfairia occidentalis as effective in improving haemoglobin levels, red blood cell counts, and other haematological indices. Mechanisms include enhanced iron absorption, antioxidant activity, and stimulation of haematopoiesis. Extraction techniques commonly used were high-performance liquid chromatography (HPLC) and aqueous methods. Key phytochemicals like flavonoids, saponins, and phenolic compounds played critical roles in IDA management. Despite promising outcomes, variations in treatment duration and protocols were noted, highlighting the need for standardisation. Conclusion Plant-based therapies offer accessible, cost-effective solutions for managing IDA in East Africa, leveraging local resources and phytochemical properties. However, further pharmacological and toxicological studies are essential to confirm safety and efficacy. This review emphasises the potential of medicinal plants in addressing IDA and calls for the exploration of underutilised plant species and the development of standardised therapeutic protocols.

Mycoplasma bovis (M. bovis) is a significant pathogen in cattle that causes respiratory disease, mastitis, and arthritis, leading to substantial economic losses globally. Early detection of M. bovis is crucial for its effective management because of its immune evasion strategies and resistance to antimicrobial therapies. In this review, we systematically assessed the diagnostic potential of P48 protein, an immunodominant lipoprotein of M. bovis, along with other potential biomarkers. The aim was to provide a comprehensive understanding of P48’s diagnostic utility through both literature analysis and computational insights. A literature search across major databases identified 243 relevant articles, 20 of which were selected based on predefined inclusion criteria. These studies consistently highlight P48’s diagnostic value due to its stability, immunodominance, and strong antibody response in infected cattle. In addition, a molecular analysis using the Expasy ProtParam tool reveals that P48 exhibits favorable properties for diagnostics, including a theoretical isoelectric point (pI) of 7.14, an instability index of 23.64 (classifying it as stable), and an aliphatic index of 83.40, indicating significant thermostability. The review also considers other diagnostic proteins, such as Variable Surface Proteins (VSPs), MbovP proteins, and MilA, although their variable nature and lesser validation across assays limit their broader application. In contrast, P48 is a reliable and specific marker, particularly in serological assays, for the early and accurate detection of M. bovis infections. This study confirms P48’s diagnostic efficacy over other biomarkers, and advocates its inclusion in diagnostic protocols.